Efficacy of Kinesiotape on Treatment of Nonspecific Cardiac Chest Pain

NCT ID: NCT06350188

Last Updated: 2024-04-05

Basic Information

• Recruitment Status: ACTIVE_NOT_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 30 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-03-22
• Study Completion Date: 2024-07-22

Brief Summary

purpose of the study To investigate the effect of Kinesio-tape on treatment of nonspecific cardiac chest pain

Detailed Description

Nonspecific musculoskeletal chest pain is a major health problem and is a very common and functionally limiting pain complaint. Patients with this problem complain also of significant disability of daily living activities and lost productivity.

The clinical symptom of anterior chest pain generally elicits a long list of diagnoses, when cardiac and pleural conditions are excluded, conditions that affect the musculoskeletal system become important considerations.

The musculoskeletal structures of the thoracic wall and the neck are relatively common sources of chest pain, hypersensitive loci, named myofascial trigger points in the literature, are associated with the Pathophysiology and clinical manifestation of myofascial pain, Rhomboid Muscle trigger point can be a distressing cause of chest pain which can be effectively taken care of by Ischemic compression therapy. Rhomboid muscle trigger points are one of the major causes of nonspecific cardiac chest pain that make the patient seek treatment in different medical health care, but still there is a lake of scientific evidence that supports a particular treatment. Conducting the current study will find an additional solution for this problem.

Kinesio-Taping a technique highly appropriate in patients with soft tissue involvement and plays a major role in the deactivation of trigger points, KT is theorized to have several functions: (1) restoring correct muscle function by supporting weakened muscles, (2) reducing congestion by improving the flow of blood and lymphatic fluid, (3) decreasing pain by stimulating neurological system, (4) correcting misaligned joints by retrieving muscle spasm, and (5) enhancing proprioception through increased stimulation to cutaneous mechanoreceptors

Conditions

Nonspecific Cardiac Chest Pain

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

experimental

the patient will receive kinsiotape therapy

Group Type: EXPERIMENTAL

experimental

Intervention Type: OTHER

15 patients ˃receive kinisio-tape ,2 session / week for 2 weeks. Followed by stretching exercises, they will be assessed pre and immediately post application, after two weeks and follow up after one month

traditional

the patient will receive traditional therapy

Group Type: ACTIVE_COMPARATOR

traditional

Intervention Type: OTHER

15 patients ˃ will receive ischemic pressure release followed by stretching exercises 2 session / week for 2 weeks, will be assessed pre and immediately post application, after two weeks and follow up after one month.

Interventions

experimental

15 patients ˃receive kinisio-tape ,2 session / week for 2 weeks. Followed by stretching exercises, they will be assessed pre and immediately post application, after two weeks and follow up after one month

Intervention Type: OTHER

traditional

15 patients ˃ will receive ischemic pressure release followed by stretching exercises 2 session / week for 2 weeks, will be assessed pre and immediately post application, after two weeks and follow up after one month.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• 30 subjects from both sexes with nonspecific cardiac chest pain 2- Rhomboid trigger point 3-All subjects range from 7 to 9 on VAS. 4-Age range from 20-35. 5- All subjects will complain from limited shoulder ROM

Exclusion Criteria

• Acute coronary syndrome/ ischemic heart disease 2-Pleurisy 3-Pulmonary lessons like(COPD) Chronic Obstructive Pulmonary Disease,( COAD) Chronic Obstructive Airway Disease and Bronchiectasis, 4-Costochondritis, ' 5-Teitze syndrome, 6-Chest wall syndrome 7-Rheumatologic conditions, 8-Infections in the chest wall 9-Gastro-intestinal problems and 10-Neoplastic disorders

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 35 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Cairo University

OTHER

Sponsor Role: lead

Responsible Party

Huda Badr Abd El Hamed

principle investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Huda Badr Abd Elhamed

Cairo, , Egypt

Countries

Egypt

Other Identifiers

ECM#2024-506

Identifier Type: -

Identifier Source: org_study_id